Search
2003 / 02 / 14
Prev, Next – Page 1 of 1 (4 documents)
1997 Statin Cost Utility Analysis (Technology Assessment Report No. 1)
(59 pages, 630 KB)
2003/02/14
This paper describes a model which PHARMAC has developed to assess the costs and benefits of extending subsidy criteria for lipid-modifying agents (LMAs). The model assesses both need for and cost-effectiveness/benefits of these agents. Impact is in terms of costs and benefits, from two perspectives: 1. a financial perspective (costs and savings for pharmaceuticals), and 2. a health economic perspective (pharmaceuticals, plus other impact on health sector costs, mortality and quality of life).
1997 Statins for Familial Hyperlipidaemia (Technology Assessment Report No. 2)
(15 pages, 237 KB)
2003/02/14
This paper examines the incremental benefits and costs of treating patients with familial hyperlipidaemia with simvastatin 40mg/day, over and above the net costs and benefits of treatment with fluvastatin 80mg/day. The analysis assumes that for familial hyperlipidaemia that benefit is proportional to the degree of LDL-cholesterol lowering, given the lack of evidence for this condition.
Request for Proposals – Supply of peak flow meters
(11 pages, 31 KB)
2003/02/14
PHARMAC invites proposals for the supply of peak flow meters in New Zealand.
Summary – Cost utility analysis of the lipid modifying agents
(10 pages, 244 KB)
2003/02/14
1997 Summary – cost utility analysis of the lipid modifying agents. The benefits of LMAs can be measured in quality-adjusted life years saved (QALYS), which combine fatal with non-fatal events.
Search tips
Search or Browse
To search for a document enter a search term into the search form and activate the Search button.
Documents may be browsed by date, eg; Today, November, 2008.
Past years can be browsed too...
2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998.
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2008
Search terms
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReport, AnnualReview, archive, BIM, BoardPaper, BusinessPlan, CAC, CACminutes, consultation, delete, EC, ECForm, EOI, etender, herceptin, inpharmation, leaflet, media, notification, OIA, opinion, PatientGuide, policy, poster, PTAC, PTACminutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, SectionH, SOI, TAR, tender, update, vacancy, WhatsNew.
Documents with related dates can be browsed through the date component links below the document title.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
